Keywords: UK, NICE< Abilify, Bristol-Myers Squibb, Servier, Protelos. Otsuka, Schizophrenia, Osteoporotic fracture

UK’s NICE backs Abilify for teenagers; sticks with guidance on Servier’s Protelos

Article | 27 January 2011

Print This

In final guidance published yesterday, the UK’s National Institute for Health and Clinical Excellence (NICE) has recommended Abilify ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in